NRC
National Research
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: NRC
- PE Ratio
As of Aug 14, 2026, the NRC stock has a P/E ratio of 88.29. The calculation is based on the latest EPS of $0.24 and the stock price of $21.19 per share. An increase of 86% has been observed in the PE ratio compared to its average of 47.5 of the past four quarters.
NRC PE ratio history
The mean historical PE ratio of National Research over the last ten years is 37.02. The current 88.29 price-to-earnings ratio is 138% more than the historical average. Analyzing the last ten years, NRC's PE ratio reached its highest point in the Jun 2026 quarter at 89.88, with a price of $21.57 and an EPS of $0.24. The Mar 2025 quarter saw the lowest point at 12.31, with a price of $12.8 and an EPS of $1.04.
National Research PE ratio by year
Maximum annual increase: 123.45% in 2025
Maximum annual decrease: -48.88% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 37.54 | 123.45% | $18.77 | $0.5 |
| 2024 | 16.8 | -46.5% | $17.64 | $1.05 |
| 2023 | 31.4 | 7.76% | $39.56 | $1.26 |
| 2022 | 29.14 | 3.19% | $37.3 | $1.28 |
| 2021 | 28.24 | -2.25% | $41.52 | $1.47 |
| 2020 | 28.89 | -43.04% | $42.75 | $1.48 |
| 2019 | 50.72 | 43.64% | $65.94 | $1.3 |
| 2018 | 35.31 | -48.88% | $38.14 | $1.08 |
| 2017 | 69.07 | 78.11% | $37.3 | $0.54 |
| 2016 | 38.78 | 1.54% | $19 | $0.49 |
| 2015 | 38.19 | 20.09% | $16.04 | $0.42 |
| 2014 | 31.8 | -37.48% | $13.99 | $0.44 |
| 2013 | 50.86 | 4.16% | $18.82 | $0.37 |
| 2012 | 48.83 | 9.46% | $18.07 | $0.37 |
| 2011 | 44.61 | 68.02% | $12.94 | $0.29 |
National Research PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 89.88 | 101.16% | $21.57 | $0.24 |
| Mar 2026 | 44.68 | 19.02% | $16.98 | $0.38 |
| Dec 2025 | 37.54 | 108.56% | $18.77 | $0.5 |
| Sep 2025 | 18 | -17.51% | $12.78 | $0.71 |
| Jun 2025 | 21.82 | 77.25% | $16.8 | $0.77 |
| Mar 2025 | 12.31 | -26.73% | $12.8 | $1.04 |
| Dec 2024 | 16.8 | -16.96% | $17.64 | $1.05 |
| Sep 2024 | 20.23 | 6.64% | $22.86 | $1.13 |
| Jun 2024 | 18.97 | -40.14% | $22.95 | $1.21 |
| Mar 2024 | 31.69 | 0.92% | $39.61 | $1.25 |
| Dec 2023 | 31.4 | -17.19% | $39.56 | $1.26 |
| Sep 2023 | 37.92 | 3.72% | $44.37 | $1.17 |
| Jun 2023 | 36.56 | 2.52% | $43.51 | $1.19 |
| Mar 2023 | 35.66 | 22.37% | $43.51 | $1.22 |
| Dec 2022 | 29.14 | 1.78% | $37.3 | $1.28 |
NRC Price vs fair value
NRC average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
NRC's current PE ratio is higher than the 3, 5 and 10-year averages.
PE comparison
With a price to earnings (P/E) of 88.29, NRC stands higher than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 23.99, National Research's price to earnings (P/E) is 268% higher.
Frequently asked questions
What is National Research's PE ratio?
The price to earnings ratio for NRC stock is 88.29 as of Aug 14, 2026.
What is the 3-year average PE ratio for National Research (NRC)?
Over the last 3 years, the average PE ratio for NRC stock is 31.77.
What is the 5-year average PE ratio for National Research (NRC)?
Over the last 5 years, the average PE ratio for NRC stock is 31.16.
What is the highest PE ratio for NRC?
Over the last ten years, the quarterly PE ratio reached its highest level at 89.88 in the Jun 2026 quarter.
How does the current PE ratio for NRC compare to its historical average?
NRC's current price to earnings ratio is 138% above its 10-year historical average.
Why is National Research's PE ratio so high?
NRC's stock price is trading at a higher multiple of earnings, which is why its PE ratio of 88.29 is considered high.
How is NRC's PE ratio calculated (National Research PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Aug 14, 2026), National Research's share price is $21.19. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $0.24. Therefore, National Research's price to earnings ratio for today is 88.29. PE RATIO(88.29) = STOCK PRICE($21.19) / TTM EPS($0.24)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.